AI Startups

    OpenAI partners with Novo Nordisk to accelerate drug discovery and delivery

    Artificial intelligence powerhouse OpenAI Group PBC is lending its expertise to Novo Nordisk A/S in a new partnership announced today that aims to accelerate research in the pharmaceutical industry. The sweeping collaboration will see OpenAI’s intelligent agents embedded across t...

    S

    SiliconANGLE

    Source

    OpenAI partners with Novo Nordisk to accelerate drug discovery and delivery
    AI Analysis

    Generated insight by OnAirToday AI

    This partnership signifies a major leap in applying advanced AI to the intricate and time-consuming process of drug discovery. By integrating OpenAI's capabilities, Novo Nordisk aims to significantly speed up the identification and development of new therapies, potentially leading to faster patient access to life-saving medications.

    Powered by AI • Not a substitute for human analysisMore Insights →
    Read the full story at SiliconANGLE →

    Get the day's AI news in one short email. Free.

    Share
    Filed under:AI Startups

    Comments

    Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.

    0/1000

    Subscribe to our Free AI Newsletter

    The Daily AI Digest, every morning. Pick your topics after you subscribe.

    Free. Unsubscribe anytime.